Thursday 16 August 2018

Breast Cancer Drug Promising in Phase 3 Trial

An experimental drug could improve survival for women with breast cancer who have the BRCA1 and BRCA2 gene mutations, a new study says.



from WebMD Health https://ift.tt/2Mxabwn

0 comments:

Post a Comment